For instance, Wan et al. (2021) showed that GRM4 played an important role in negatively modulating antitumor immunity, and global GRM4 knockout or pharmacological inhibition of GRM4 led to a significant inhibition of tumor growth in multiple tumor models. This evidence concerns the gene GRM4 and neoplasm.